- Home
- SENEA vs KRRO Comparison
SENEA vs KRRO Comparison
Compare SENEA & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SENEA | KRRO |
|---|---|---|
| Founded | 1949 | 2014 |
| Country | United States | United States |
| Employees | 6895 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.4M | 105.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SENEA | KRRO |
|---|---|---|
| Price | $142.97 | $11.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $34.80 |
| AVG Volume (30 Days) | 59.1K | ★ 207.0K |
| Earning Date | 02-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,392,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | N/A | ★ 181.46 |
| 52 Week Low | $81.00 | $5.20 |
| 52 Week High | $148.97 | $55.89 |
Technical Indicators
Market Signals| Indicator | SENEA | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 46.30 |
| Support Level | $101.00 | $10.55 |
| Resistance Level | $148.97 | $12.54 |
| Average True Range (ATR) | 6.42 | 0.88 |
| MACD | -0.45 | -0.05 |
| Stochastic Oscillator | 68.16 | 14.18 |
Price Performance
Historical ComparisonAbout SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.